NewsBenzinga이머전트 바이오솔루션, 3분기 조정 주당순손실 0.36달러로 예상치 0.39달러 상회, 매출 1억 1천만 달러로 예상치 1억 2,320만 달러 하회 이머전트 바이오솔루션, 3분기 조정 주당순손실 0.36달러로 예상치 0.39달러 상회, 매출 1억 1천만 달러로 예상치 1억 2,320만 달러 하회 Benzinga 2026.11.02 21:08 (GMT+0) Open on Benzinga Other news RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $125 Leerink Partners Maintains Outperform on Cencora, Raises Price Target to $405 RBC Capital Maintains Outperform on Zillow Group, Lowers Price Target to $38 RBC Capital Maintains Sector Perform on Wayfair, Raises Price Target to $128 Leerink Partners Maintains Outperform on CVS Health, Lowers Price Target to $104 RBC Capital Maintains Sector Perform on W.W. Grainger, Raises Price Target to $1582
